Massimo Di Nicola
6PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 06, 2024
Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden.Michael Schenker, Mauricio Burotto, Martin Richardet
|Mar 31, 2022
BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer.Francesca De Santis, Sandra L Romero-Cordoba, Lorenzo Castagnoli
|Aug 07, 2021
Nanobiotechnology and Immunotherapy: Two Powerful and Cooperative Allies against Cancer.Francesco Mainini, Francesca De Santis, Giovanni Fucà
|Jul 12, 2018
Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cells.Alessandro Satta, Delia Mezzanzanica, Francesco Caroli
|Jul 22, 2017
Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat.Anna Rossini, Franco Zunino, Giusi Ruggiero
Pageof 1
Frequent Collaborators
2 joint publications
Mariangela Figini
2 joint publications
Silvana Canevari
1 joint publications
Anna Rossini
1 joint publications
Franco Zunino
1 joint publications
Giusi Ruggiero
1 joint publications
Denis Cominetti
1 joint publications
Monica Tortoreto
1 joint publications
Cinzia Lanzi
1 joint publications
Michele Del Vecchio
1 joint publications
Roberta Zappasodi